Hunger Games: Why Diets Fail and Weight Loss Medicines Succeed

Controlling hunger, not calories, is the Holy Grail of weight loss.

Updated February 23, 2026 | Reviewed by Michelle Quirk

After a century of futility, the seemingly impenetrable mystery of weight loss is nearly solved. Until late 2022, most of us were taught that the weight loss journey was paved with willpower . Our Sisyphean task was to create a caloric deficit through diet and exercise and maintain it indefinitely through deliberate effort, food, and activity tracking, and enduring lifestyle changes. For the minority, this formula succeeded. 1 Yet most people found that weight loss was a revolving door: No matter the method or the motivation , their weight eventually returned to roughly the same starting point. 2

Then something unexpected happened. Following decades of clinical trials yielding ineffective or even dangerous weight loss medicines, 3 a new class of injectable medicines called GLP-1 agonists (GLP=glucagon-like peptide) arrived in 2022-2023. 4 Not only did the average GLP-1 user experience weight loss far surpassing that usually achieved through lifestyle changes alone, their weight loss generally came with minimal conscious effort. For the first time, people were suddenly achieving clinically significant weight loss without tracking calories, practicing specific diets, or willpowering themselves through high-volume exercise routines. The weight loss journey, for millions, had transformed from an uphill slog to a stroll in the park.

The purpose of this post is to explain this weight loss paradigm change, including how it benefits GLP-1 users and non-users alike. The greatest breakthrough from the GLP-1 medicine era was arguably not the novel psychopharmacology . It was shattering the illusion that weight loss was ever about calorie counting, exercise, or controversial diets. Weight loss, instead, was always about controlling hunger. 5

Turns out that weight loss was a real-life "Hunger Games." GLP-1 medicines simply offered us a reliable strategy for finally winning the game.

Winning the Hunger Games

To understand the remarkable effectiveness of bariatric surgery and GLP-1 medicines compared to traditional diet and exercise programs for weight loss, you must understand hunger. Surprisingly to many people, the human body doesn't possess an internal calorie detector. Your body doesn't know if you've eaten 500 calories or 5,000. Instead, our body evolved to rely on biological proxy systems that, until the recent era of ultra-processed food, functioned extraordinarily well to regulate our weight and appetite across times of feast and famine. These systems include:

Consider the above mechanisms in understanding why many diets and exercise programs fail for long-term weight loss.

Increased hunger is the predictable result. And if hunger is a horse, weight gain is the wagon it pulls closely behind.

The modern era of ultra-processed food consumption also appears to have driven dramatic rises in obesity and obesity-related health condition rates (e.g., diabetes, liver disease, many forms of cancer) by bypassing the above human satiety mechanisms. For instance:

Through precisely the same hunger mechanisms through which diets generally fail, bariatric surgery and GLP-1 medicine succeed.

No matter how you approach your goal of healthy weight loss, hunger is likely to be your most formidable opponent. Although the methods by which they control hunger vary, every effective dietary, physical activity, surgical, and medicinal approach to weight loss capitalizes on known human hunger and satiety mechanisms. In contrast, weight loss methods that fail to adequately control hunger through one or more of these mechanisms rarely produce lasting weight loss. All of us seeking long-term healthy weight management can benefit from the revelations yielded by the new GLP-1 medicines in enhancing our results.

Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005 Jul;82(1 Suppl):222S–225S. doi: 10.1093/ajcn/82.1.222S. PMID: 16002825.
Hall KD, Kahan S. Maintenance of Lost Weight and Long-Term Management of Obesity. Med Clin North Am. 2018 Jan;102(1):183–197. doi: 10.1016/j.mcna.2017.08.012.
Li MF, Cheung BM. Rise and fall of anti-obesity drugs. World J Diabetes. 2011 Feb 15;2(2):19–23. doi: 10.4239/wjd.v2.i2.19.
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205–216. doi: 10.1056/NEJMoa2206038.
Astrup, A. Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions. Eur J Clin Nutr 78, 551–556 (2024). https://doi.org/10.1038/s41430-024-01460-6
Lewis, S. A good stretch regulates satiety. Nat Rev Neurosci 21, 1 (2020). https://doi.org/10.1038/s41583-019-0252-z
Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010 Jan 19;152(2):93–100. doi: 10.7326/0003-4819-152-2-201001190-00008.
Williams EK, Chang RB, Strochlic DE, Umans BD, Lowell BB, Liberles SD. Sensory Neurons that Detect Stretch and Nutrients in the Digestive System. Cell. 2016 Jun 30;166(1):209–21. doi: 10.1016/j.cell.2016.05.011. Epub 2016 May 26. Erratum in: Cell. 2025 Jun 26;188(13):3623-3624. doi: 10.1016/j.cell.2025.05.043.
de Macedo IC, de Freitas JS, da Silva Torres IL. The Influence of Palatable Diets in Reward System Activation: A Mini Review. Adv Pharmacol Sci. 2016;2016:7238679. doi: 10.1155/2016/7238679.
Redman LM, Heilbronn LK, Martin CK, de Jonge L, Williamson DA, Delany JP, Ravussin E; Pennington CALERIE Team. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One. 2009;4(2):e4377. doi: 10.1371/journal.pone.0004377.
Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr. 2008 May;87(5):1558S–1561S. doi: 10.1093/ajcn/87.5.1558S.

Share this post Facebook Bluesky Linkedin Email

There was a problem adding your email address. Please try again.

By submitting your information you agree to the Psychology Today Terms & Conditions and Privacy Policy

Thomas Rutledge, Ph.D. , is a Professor-in-Residence in the Department of Psychiatry at UC San Diego and a staff psychologist at the VA San Diego Healthcare System.

Get the help you need from a therapist near you–a FREE service from Psychology Today.

This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.